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Histological classification of laryngeal epithelial lesions is highly subjective, and methods of cytological detection are not well
developed. Improved determination of aberrant cell cycle entry may allow increased objectivity in histological assessment and enable
the development of less invasive diagnostic cytology tests. Sections of normal larynx (n¼10), laryngeal dysplasia (n¼20) and
laryngeal squamous cell carcinoma (SCC) (n¼10) were classified according to the Ljubljana classification and stained for markers of
cell cycle entry, minichromosome maintenance protein-2 (Mcm-2) and Ki67. Expression patterns were compared using double
labelling confocal microscopy. There was a correlation between Mcm-2 and Ki67 labelling indices (r¼0.93; 95% CI [0.84, 0.97]) and
both markers showed increased expression from normal epithelium to SCC (Mcm-2, P¼0.001; Ki67, P¼0.0002). Importantly, there
was minimal expression of Mcm-2 or Ki67 in the most superficial layers of normal larynx and abnormal or atypical hyperplasia, in
contrast to carcinoma in situ and SCC. Clusters of Mcm-2/5-positive cells were present in cytological preparations from SCC, but not
from those showing atypical hyperplasia or inflammation in non-neoplastic tissue. Minichromosome maintenance protein-2 staining
may increase the objectivity and reliability of histological grading of laryngeal epithelial lesions. Laryngeal brushings, combined with
immuno-enhanced liquid-based cytology, could be useful, as a less invasive approach, to the detection of laryngeal malignant and
premalignant lesions.
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Along with carcinoma of the oral cavity, laryngeal squamous cell
carcinoma (SCC) is the most common primary tumour of the
head and neck, excluding the skin (Watkinson et al, 2000; Weiss
and Goldblum, 2001). It progresses through several premalignant
or dysplastic stages in a manner broadly similar to that of cervical
SCC (Hellquist et al, 1999; Gale et al, 2000; Weiss and Goldblum,
2001). Diagnosis and differentiation of the different grades of
dysplastic laryngeal lesions has traditionally been accomplished by
histological analysis, although it is widely acknowledged that
currently available criteria give rise to an inevitable degree of
subjectivity. Such histological variability is not helped by the fact
that precancerous lesions of the larynx have no specific laryngo-
scopic appearances and can be variously interpreted as chronic
laryngitis, leukoplakia, keratosis or erythroplakia (Gale et al,
2000; Weiss and Goldblum, 2001). It is important, therefore, to
improve the criteria for histological diagnosis of different grades of
dysplasia and to be able more reliably to differentiate those lesions
likely to progress to invasive malignancy from those lesions likely
to regress or respond to conservative treatment.
Laryngeal dysplasia (LD) has traditionally been classified in a
similar fashion to premalignant lesions of the cervix (Kambic and
Gale, 1995; Kambic, 1997). In the WHO classification, for example,
a minor degree of atypical change confined to the basal third of the
squamous epithelium is defined as laryngeal dysplasia grade 1
(LD-1). In LD-2, there is involvement of the basal one-third to two-
thirds of the epithelium and LD-3 includes carcinoma in situ and
severe dysplasia, with or without surface keratosis, in which atypia
involves at least the basal two-thirds of the epithelium (Michaels, 1992).
There are major aetiological differences between carcinomas of
the larynx and the cervix, particularly in respect of the importance
of human papilloma virus (HPV). In contrast to its role in the
cervix, HPV appears to be of relatively minor significance in the
generation of LD (Kambic, 1977; Smith et al, 2000). The Ljubljana
classification of LD (Hellquist et al, 1999) takes into account the
differences in the aetiology and pathology of laryngeal compared
to cervical lesions. The histological system comprises four grades.
Simple hyperplasia and abnormal hyperplasia (corresponding to
simple squamous cell hyperplasia in the WHO scheme) are
regarded as benign lesions. Atypical hyperplasia (WHO: LD-1 and
LD-2) is a lesion with some risk of development of invasive
carcinoma. Carcinoma in situ (WHO: LD-3 and carcinoma in situ)
is a lesion with a high risk of development of invasive carcinoma
(Hellquist et al, 1999). These subdivisions broadly reflect those of
other classification systems, although it is felt that the Ljubljana
method more reliably predicts those lesions that are likely to
progress to invasive carcinoma. Received 17 February 2003; revised 26 June 2003; accepted 8 July 2003
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yProgrammes for the early detection of premalignant and
malignant disease of the larynx are not yet well developed, largely
because of the difficulties inherent in examining this organ.
Examination has to be performed under general anaesthesia and
the small, but not insignificant risk involved in taking biopsies
prevents this from occurring unless the clinical index of suspicion
is high. To further complicate matters, premalignant conditions do
not show gross diagnostic appearances, which can be identified
under direct endoscopy (Kambic, 1997; Watkinson et al, 2000).
Less invasive diagnostic tests are required if safety, affordability
and patient compliance rates are to improve.
Previous reports have suggested that laryngeal brushings are of
limited value for early diagnosis, because of a poor yield of surface
epithelial cells, contamination with blood necrotic debris and
surface keratosis (Vowles et al, 1997). However, these studies were
performed before modern cytological techniques were widely
available. With the application of liquid-based cytological techni-
ques, coupled with novel biomarkers used to detect neoplastic cells
(Biscotti et al, 2002; Davies et al, 2002), laryngeal brushing may
now represent a viable less-invasive technique for the detection of
neoplasia in the larynx, as has been shown to be the case in cervix
and colon (Williams et al, 1998; Davies et al, 2002).
Promising biomarkers for improving cancer detection include
the minichromosome maintenance (MCM) proteins (MCMs 2–7),
which assemble in the prereplication complex and are essential for
DNA replication in eukaryotic cells (Kearsey and Labib, 1998). All
six proteins are abundant throughout the cell cycle and are broken
down rapidly on differentiation and more slowly in quiescence
(Maiorano et al, 1996; Kearsey and Labib, 1998; Musahl et al, 1998;
Tanaka and Diffley, 2002). Antibodies against MCMs detect more
cells in tissues than other ‘proliferation’ markers such as Ki67
(Todorov et al, 1998; Williams et al, 1998; Freeman et al, 1999). We
and others have shown that immunocytochemical staining for
MCMs such as Mcm-2 or Mcm-5 may be of value in identifying
malignant or premalignant lesions in a range of clinical specimens
(Todorov et al, 1998; Williams et al, 1998; Freeman et al, 1999;
Stoeber et al, 1999; Meng et al, 2001; Davies et al, 2002; Going et al,
2002; Hunt et al, 2002; Rodins et al, 2002).
In the present study, we have investigated different grades of LD
for expression of markers of cell cycle entry (Mcm-2 and Ki67) and
have used double-labelling confocal microscopy to compare the
expression of Mcm-2 and Ki67 in individual specimens. We have
compared levels of expression of both markers in LD with those
seen in normal epithelium and laryngeal SCC. In particular, we
have assessed the distribution of staining in the superficial third of
the laryngeal epithelium, to determine whether or not there is any
potential for exploiting aberrant surface expression of Mcm-2 to
detect precancerous lesions cytologically by brushing the epithe-
lium at laryngoscopy. Based on our findings, we have undertaken a
small pilot study to examine whether immunocytochemical
analysis of MCM expression in liquid-based cytology specimens
from laryngeal brushings may represent a sensitive and novel
approach to detection of malignant and potentially premalignant
laryngeal lesions.
MATERIALS AND METHODS
Clinical specimens
Blocks of paraffin-embedded, formalin-fixed human larynx,
obtained from surgical resection specimens, were obtained in
accordance with Local Research Ethics Committee guidelines.
The tissues examined represented normal laryngeal squamous
epithelium taken from excision margins distant from a resected
tumour (n¼10), LD (n¼20) and laryngeal SCC (n¼10). The 20
dysplastic lesions were graded according to the Ljubljana
classification. Of these 20 dysplastic lesions, 10 showed atypical
hyperplasia in the Ljubljana classification and 10 represented
carcinoma in situ. Of the 10 lesions classified as carcinoma in situ,
five corresponded to LD-3 (WHO) and five represented carcinoma
in situ in the WHO scheme.
Primary antibodies
Mouse monoclonal antibodies raised against Mcm-2 (Mukherjee
et al, 2001; Davies et al, 2002), Mcm-5 (Mukherjee et al, 2001) and
Ki67 (Mib-1 clone, DAKO, Ely, UK) were used.
Immunohistochemistry
Sections (5mm) were cut onto aminopropyltriethoxysilane (APES)-
coated slides and processed for immunohistochemistry, as
described previously (Freeman et al, 1999).
Primary antibody (100ml) was applied in a humidified chamber
at 41C overnight with gentle shaking in 1% BSA/TBS with 0.1%
Triton X-100. The slides were then washed in TBS containing
0.025% Triton X-100 and incubated for 1h with biotinylated goat
anti-mouse secondary antibody (DAKO, Ely, UK). A streptavidin–
horseradish peroxidase system (DAKO, Ely, UK) with the substrate
diaminobenzidine was used to develop the stain. The slides were
then lightly counterstained with Harris’ haematoxylin, dehydrated
in increasing concentrations of alcohol and cleared in xylene.
Coverslips were applied with DEPEX mounting medium (Gurr,
BDH, Poole, Dorset, UK).
Negative controls were performed, for all tissues studied, by
omitting the primary antibody. Sections of cervix showing various
grades of cervical intraepithelial neoplasia were used as positive
controls (Freeman et al, 1999).
Double labelling immunofluorescence for confocal
microscopy
In order to examine the differential expression of Mcm-2 and
Ki67 in individual specimens, double labelling immunofluores-
cence experiments were performed on sections of all grades of
epithelium (n¼6).
The sections were prepared as described above. No quenching of
endogenous peroxidase was necessary. The Mcm-2 antibody was
applied first and, after washing, the sections were incubated with
Alexa Fluro goat anti-mouse 488 (Molecular Probes, Eugene, OR,
USA). This was followed by a blocking step with F(ab)2 goat anti-
mouse IgG fragments (Jackson Immuno Research Laboratories,
West Grove, PA, USA). A further washing step was then performed
before incubation with the Ki67 antibody. Following a final
washing step and incubation in Alexa Fluro goat anti-mouse 546
(Molecular Probes), the slides were counterstained and mounted as
described above. As an internal control, the order of application of
the primary antibodies was reversed.
Images were viewed and assessed using a Zeiss Axioplan 2
confocal microscope at wavelengths of 488 and 546nm.
Quantification of antibody staining
For each marker, a semiquantitative indication of staining fre-
quency was determined by calculating a labelling index (LI). In the
normal larynx and in lesions showing epithelial hyperplasia or
carcinoma in situ, the epithelium was divided into equal thirds.
The ratio of immunopositive to total epithelial cells was deter-
mined for the entire epithelium and for four epithelial compart-
ments, the superficial, middle and lower thirds of the epithelium
and the basal layer. In the SCCs, where epithelial orientation is lost,
the LI was determined as a mean of five individual counts. The
counts were repeated independently by four observers (PC, ISS,
LSM, RJD), and an interobserver variation of less than 5% was
seen. The overall LI values used represented a mean of the LIs from
the four observers.
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The cytological study was performed with the approval of the
Cambridge, Harold Wood and Royal Free Hospital Local Research
Ethics Committees. Patients undergoing laryngeal biopsy under
general anaesthesia for clinically suspicious lesions of the larynx
were first submitted to brushing of the mucosa overlying the lesion
using a Micro-invasive Brush (Boston Scientific, Watertown, MA,
USA). This was applied firmly but without undue pressure for a
period of 5s, following which the tip was cleanly amputated using
wire cutters and dropped into PreservCyt
s solution (Cytyc
Corporation, Boxborough, MA, USA). The solution was then
filtered through a TransCyt
s filter and the cellular material
deposited on a slide in a ThinPrep 2000
s cytoprocessor according
to the manufacturer’s protocols (Cytyc Corporation).
Immunocytochemical staining of the slides was performed on a
DAKO Universal Stainer (DAKO, Ely, Cambs, UK). The slides were
treated with 4mM sodium deoxycholate and washed in TBS. A
combination of Mcm-2 and Mcm-5 primary antibodies was used
and a DAKO Chem Matet HRP-detection kit was employed for all
subsequent steps. The slides were counterstained with a modified
Papanicolaou method (Williams et al, 1998) on a Leica Autostainer
XL (Leica, Houston, TX, USA) and were then mounted in DPX.
Slides were evaluated by two observers (ISS, LSM), who were
blind to the histological diagnosis made in the biopsy. Slides
were assessed for Mcm-2/5 immunopositivity and for any atypia
demonstrated by the modified Papanicolaou counterstain. The
accompanying biopsies were stained with haematoxylin and eosin
and also by immunohistochemistry for expression of Mcm-2.
Statistical analysis
Differences between Mcm-2 and Ki67 LIs were compared using the
Bland and Altman limits of agreement analysis. Labelling indicies
were compared using the Friedman test, and pairwise comparisons
between normal larynx and dysplasia were made using the Mann–
Whitney U-test. Differences in LIs in the progression from normal
larynx through the various grades of hyperplasia and carcinoma in
situ to SCC were assessed using the Jonckheere–Terpstra test. For
initial comparisons, the hyperplastic and carcinoma in situ sub-
divisions were analysed together to give greater statistical power.
RESULTS
Immunohistochemical staining
Sections of normal laryngeal epithelium showed a normal pattern
of maturation from the basal layer to the surface (Figure 1A). Very
little surface keratin was seen in the absence of inflammation.
Expression of Mcm-2 and Ki67 was detected in occasional cells
within the basal layer (Figure 1B and C). There was expression of
Mcm-2 in approximately 60% of cells in the lower third of the
epithelium. Very few cells were positive in the middle third and
there was no staining with either antibody in the superficial third.
In lesions showing abnormal or atypical hyperplasia (Figure 1D),
Mcm-2 and Ki67 were expressed in the lower and middle thirds,
with only occasional cells being positive in the surface layers
(Figure 1E and F).
In lesions showing carcinoma in situ (WHO: LD-3, CIS),
dysplastic cells occupy the lower and middle thirds and extend
into the superficial third of the epithelium (Figure 1G). In these
high-grade lesions, Mcm-2 and Ki67 immunopositive cells
were abundant in all three layers, with frequent extension to the
epithelial surface (Figure 1H and I). In addition, occasional cells
showing Mcm-2 and Ki67 immunoreactivity appeared to have
sloughed away from the epithelial surface (Figure 1H and I).
We also observed areas of dysplasia in squamous metaplasia
arising in regions originally showing a respiratory-type (pseudo-
stratified) columnar epithelium (Figure 1J). These areas also
showed full-thickness expression of both Mcm-2 and Ki67 (Figure
1K and L).
In SCC, there was widespread expression of both Mcm-2 and
Ki67, with mean LIs of 80.6 and 63.9%, respectively.
Mcm-2 and Ki67 LIs in different epithelial compartments
In normal larynx and in lesions showing dysplasia (atypical
hyperplasia and carcinoma in situ combined), Mcm-2 expression
decreased from the lower to the middle third and from the middle
to the superficial third (Figure 2A) (Po0.0001). Mcm-2 expression
in the basal layer was low, and was similar to that seen at the
surface. There was no overlap in Mcm-2 LI values between the four
compartments of normal epithelia analysed, although overlap was
seen for dysplastic lesions (Figure 2A).
Ki67 LIs showed similar patterns to those of Mcm-2 (Figure 2B).
In normal larynx, an increase in expression in the middle third of
the epithelium compared to the superficial third was identified,
although the LI values at these levels did overlap. There was a
sharp increase in Ki67 LI in the lower third of the epithelium
compared to the middle third, with no overlap in LI values. The
Normal larynx
H&E Mcm-2 Ki67
Abnormal hyperplasia 
Carcinoma in situ
Dysplasia arising in squamous metaplasia of respiratory-type epithelium 
H&E Mcm-2 Ki67
H&E Mcm-2 Ki67
H&E Mcm-2 Ki67
ABC
DEF
GHI
JKL
Figure 1 Immunohistochemical staining showing the distribution of
Mcm-2 (middle panel) and Ki67 (right panel) in normal laryngeal squamous
epithelium, abnormal hyperplasia, carcinoma in situ and dysplasia arising in
squamous metaplasia affecting respiratory-type epithelium. The haematox-
ylin & eosin (H&E) appearances are given for comparison (left panels). All
figures are at  200 magnification. In carcinoma in situ, there is full-
thickness staining for both markers, with clusters of immunopositive cells
that appear to have sloughed away from the epithelial surface.
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various compartments of dysplastic epithelia were also similar to
those for Mcm-2 (Figure 2B). Overall, as with Mcm-2, in normal
larynx and laryngeal dysplasia there was a highly significant
difference in Ki67 LI values between the four epithelial compart-
ments studied (Po0.0001).
Mcm-2 and Ki67 expression in atypical hyperplasia/
carcinoma in situ vs normal epithelia
Overall, there was a significant correlation between Mcm-2 and
Ki67 LIs (r¼0.93; 95% CI [0.84, 0.97]), although Mcm-2
expression was elevated when compared to Ki67 (Figure 3A).
There was an increase in median LIs for the entire epithelium of
both Mcm-2 and Ki67 in the progression from normal larynx
through dysplasia to SCC (Mcm-2, P¼0.001; Ki67, P¼0.0002)
(Figure 3B).
Mcm-2 LIs were significantly greater in lesions showing
dysplasia (atypical hyperplasia and carcinoma in situ combined)
in comparison to normal larynx in the superficial (Po0.0001),
middle (Po0.0001) and lower thirds of the epithelium (P¼0.003)
and in the basal layer (Po0.0001) (Figure 2A). Substantial
expression of Mcm-2 in the superficial third was only seen in
carcinoma in situ (WHO: LD-3, CIS), although some increase in
expression was seen in atypical hyperplasia (WHO: LD-1/2)
(Figure 4).
Ki67 LIs showed similar differences, with greater values in the
upper (Po0.0001), middle (Po0.0001) and lower (P¼0.008)
thirds and in the basal layer (Po0.0001) of dysplastic lesions when
compared to normal larynx (Figure 2B).
Confocal microscopy
In view of the greater frequency of expression of Mcm-2 compared
to Ki67 (Figures 2 and 3), we compared expression of the two
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Figure 3 (A): Correlation between Mcm-2 and Ki67 LIs for the entire
epithelium in normal larynx (n¼10), LD unaccompanied by invasive
disease (n¼10) and SCC (n¼10) (r¼0.93; 95% CI [0.84, 0.97]). (B)
Comparison between Mcm-2 and Ki67 LIs for the entire epithelium in
normal larynx (n¼8), LD unaccompanied by invasive disease (n¼10) and
laryngeal SCC (n¼10; median7IQR). Box¼upper to lower quartile
ranges; whisker¼2  quartile range; circles¼extreme values.
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fluorescence microscopy (Figure 5). In all cases, all cells expressing
Ki67 (red) also expressed Mcm-2 (green), giving a yellow signal.
No cells showing a red fluorescent signal (Ki67 alone) were
identified, indicating that Mcm-2 was present in all cells expressing
Ki67. There were, however, many cells expressing Mcm-2 (green)
that did not express Ki67 (red), in all grades of epithelium.
Laryngeal brushings
In view of the high frequency of expression of Mcm-2 in the
superficial third of dysplastic epithelia (including in sloughed
cells), we undertook a small pilot study to investigate whether
laryngeal lesions could be detected by immunocytochemical
analysis of MCM proteins in laryngeal brushings. Brushings were
obtained from lesions (n¼6) from which a biopsy was also taken
as a gold standard (Figure 6).
In two cases, histological examination showed parakeratosis and
inflammation only, with Mcm-2 staining only in the basal layer of
the epithelium. Brushings taken from these specimens showed no
cytological atypia and no evidence of Mcm-2/5 immunopositivity.
A third biopsy revealed the presence of atypical hyperplasia
(WHO: LD-1/2), with parakeratosis and koilocytosis indicating
HPV infection. Minichromosome maintenance protein-2 staining
extended into the middle third of the epithelium, but there was no
Mcm-2 expression at the epithelial surface. Cytological brushings
from this case showed mild cytological atypia, but there was no
Mcm-2/5 immunopositivity.
The remaining three biopsies all showed invasive SCC. In all
cases, immunohistochemistry for Mcm-2 showed widespread and
frequent staining of malignant cells. Brushings from these cases all
showed moderate to severe cytological atypia and the majority of
atypical cells expressed Mcm-2. Immunopositive cells stood out
clearly in the cytological preparations and were readily identified,
even at low magnification.
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Figure 4 Bar charts (median7IQR) comparing Mcm-2 LIs in different
compartments of the laryngeal epithelium in normal larynx (n¼8), atypical
hyperplasia (n¼10), carcinoma in situ (n¼9). Substantial expression of
Mcm-2 in the superficial epithelial third is only present in carcinoma in situ,
although some increase in expression above normal is seen in atypical
hyperplasia. Base¼lower epithelial third, asterisk and circle¼extreme
values.
Carcinoma in situ (×200) 
Figure 5 Double-labelling fluorescent confocal microscopy for Mcm-2
(green) and Ki67 (red) in carcinoma in situ. Many cells coexpress Mcm-2
and Ki67 (yellow), but there are also many cells showing Mcm-2-expression
alone (green). Mitotic figures show chromatin exclusion of Mcm-2 (red
staining) but the cytoplasm is positive for Mcm-2 (arrow). Some Mcm-2-
expressing cells (green) are present in the superficial third whereas very few
cells express Ki67 (yellow).
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Recent epidemiological findings suggest that there are consider-
able differences in the aetiology of cervical and laryngeal cancer. A
link between HPV infection and cervical cancer has been
demonstrated in over 99% of specimens (Walboomers et al,
1999). Recent investigations, on the other hand, do not support
HPV as an important factor in the pathogenesis of laryngeal
epithelial lesions (Brandwein et al, 1993), although the prevalence
of HPV in laryngeal carcinomas has been found to range from 5 to
54.1% (Hoshikawa et al, 1990; Perez-Ayala et al, 1990; Brandwein
et al, 1993). The aetiology of laryngeal cancer is more likely to be
related to cigarette smoking, alcohol abuse and exposure to other
extrinsic irritants. These probably trigger a series of genetic events
that differ from those in the cervix (Michaels, 1992). It would be
expected, therefore, that the histological features of precancerous
lesions of the larynx would be different from those seen in the
cervix, and this is indeed the case. The Ljubljana classification is
designed to take into account these differences and to predict more
accurately the biological behaviour of precancerous lesions of the
larynx. This is important as repeat smears/biopsies cannot readily
be performed in the larynx and there is a pressing need to
differentiate accurately between potentially malignant and actual
preinvasive carcinoma as these two lesions are treated differently
at this site (Hellquist et al, 1999).
Our comparison of the expression of Mcm-2 with that of Ki67,
an established marker of cell cycle entry, shows a direct correlation
between the frequency of expression of the two proteins. However,
Mcm-2 is detectable in greater numbers of cells at the surface
of premalignant laryngeal lesions. This observation is supported
by our double-labelling confocal microscopy data showing that
Mcm-2 is expressed not only in all Ki67-positive cells but also in
Ki67-negative cells.
Our histological data show that Mcm-2 is expressed within the
most superficial surface layers of laryngeal epithelium in cases of
carcinoma in situ and SCC, with minimal expression in abnormal
and atypical hyperplasia. We suggest, therefore, that Mcm-2 would
be a good candidate as a biomarker of premalignant and malignant
laryngeal disease. It has been suggested that the Ljubljana classi-
fication can be made more accurate with the silver-staining of
nucleolar organising regions, or using Ki67 (Grundmann, 1983).
Our data show that Mcm-2 is superior to Ki67 in the detection
of cell cycle entry in the larynx. Application of Mcm-2 immuno-
histochemistry could, therefore, increase the diagnostic accuracy
of the Ljubljana classification, and further work in this area is
warranted.
In the cervix, a comparable squamous epithelium to that of the
larynx, routine cytological surveillance has been shown to be
highly effective in identifying premalignant disease (Vizcaino et al,
2000). Cervical screening requires removal of surface epithelial
cells by scraping or brushing. Any malignant or potentially
premalignant cells so sampled can be identified using morpholo-
gical or immunocytochemical parameters. We have previously
shown that immunocytochemistry for Mcm-2 in cervical smears
enables abnormal cells to be identified with very high sensitivity
(Williams et al, 1998). Based on our immunohistochemical data in
the present study, we reasoned that, by analogy with our findings
in the cervix, if the superficial cells in the larynx are removed by
brushing, Mcm-2 expression should be detected in cytological
preparations obtained from malignant or premalignant lesions.
Importantly, such an approach would enable all of the laryngeal
epithelium to be sampled. We observed that in carcinoma in situ
and SCC, many Mcm-2-positive cells appear to be sloughed from
the epithelial surface and this should assist in the detection of these
lesions by laryngeal brushing. Indeed, our small pilot study
suggests that Mcm-2/5 immunocytochemistry combined with
liquid-based cytology may enable laryngeal SCC to be distin-
guished from hyperplastic lesions and non-neoplastic epithelium
following laryngeal brushing.
Our experience to date suggests that laryngeal brushing is a
technique that can be performed under general anaesthesia,
although ultimately it would be preferable if the technique could
100 m
50 m
50 m
C
B
A
Figure 6 Normal squamous (A) and respiratory-type (B) epithelial cells
are negative when stained with antibodies against Mcm-2/5. (C) A cluster
of cells from a laryngeal SCC, which are strongly positive for Mcm-2/5 and
were readily identified, even at low magnification.
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ybe adapted for use in the outpatient setting under topical
anaesthesia. The method causes little discomfort, is relatively cost
efficient and could provide a means of assessing large numbers of
patients with early nonspecific symptoms. Based on the results
from liquid-based cytology enhanced by immunocytochemistry for
Mcm-2/5, these patients could be divided into those requiring
further investigation and those who could be followed up without
resort to biopsy.
There is, therefore, the potential for laryngeal brushing to be
developed further in the context of less-invasive detection of early
laryngeal epithelial lesions, although this will ultimately be
dependent upon the availability of flexible nasoendoscopic
equipment and refinement of techniques to allow the use of a
fine brush as an outpatient procedure.
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